Lasers and Lights for Treating Pigmented Lesions

  • Emmy M. Graber
  • Jeffrey S. Dover


  • Pigmented lesions were initially treated with destructive non-selective lasers.

  • Now pigment selective Q-switched lasers used.

  • Pigmented skin lesions are exceedingly common.

  • Selective destruction of pigmented lesions relies on the theory of selective photothermolysis.

  • Melanin has a broad absorption spectrum with absorption steadily decreasing with increasing wavelength.

  • Several Q-switched lasers fall within the melanin absorption spectrum. Their nanosecond pulse duration is effective since it is shorter than the thermal relaxation time of melanin.


Laser Treatment Ruby Laser Thermal Relaxation Time Melanocytic Nevus Pigment Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1.  1.
    Goldman L, Blaney DJ, Kindel DJ, Franke EK. Effect of the laser beam on the skin: preliminary report. J Invest Dermatol. 1963;40:121-122.PubMedGoogle Scholar
  2.  2.
    Goldman L, Wilson RG, Hornby P, Meyer RG. Radiation from a Q-switched ruby laser: effect of repeated impacts of power output of 10 megawatts on a tattoo of man. J Invest Dermatol. 1965;44:69-71.PubMedGoogle Scholar
  3.  3.
    Ohshiro T, Maruyama Y. The ruby and argon lasers in the treatment of naevi. Ann Acad Med. 1983;12:388-395.Google Scholar
  4.  4.
    Dover JS, Smoller BR, Stein RS, et al. Low-fluence carbon dioxide laser irradiation of lentigines. Arch Dermatol. 1988;124:1219-1224.PubMedCrossRefGoogle Scholar
  5.  5.
    Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.PubMedCrossRefGoogle Scholar
  6.  6.
    Polla LL, Margolis RJ, Dover JS, et al. Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol. 1987;89:281-286.PubMedCrossRefGoogle Scholar
  7.  7.
    Levins PC, Anderson RR. Q-switched ruby laser for the treatment of pigmented lesions and tattoos. Clin Dermatol. 1995;13:75-79.PubMedCrossRefGoogle Scholar
  8.  8.
    Taylor CR, Anderson RR, Gange RW, et al. Light and electron microscopic analysis of tattoos treated by Q-switched ruby laser. J Invest Dermatol. 1991;97:131-136.PubMedCrossRefGoogle Scholar
  9.  9.
    Ara G, Anderson RR, Mandel KG, et al. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells. Lasers Surg Med. 1990;10:52-59.PubMedCrossRefGoogle Scholar
  10. 10.
    Dover JS, Margolis RJ, Polla LL, et al. Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses. Arch Dermatol. 1989;125:43-49.PubMedCrossRefGoogle Scholar
  11. 11.
    Ardnt KA, Dover JS, Olbricht SM. Lasers in Cutaneous and Aesthetic Surgery. Philadelphia: Lippincott-Raven; 1997.Google Scholar
  12. 12.
    Kossida T, Farinelli W, Flotte T, et al. Mechanism of immediate whitening during tattoo Removal. Lasers Surg Med. 2006;18:70.Google Scholar
  13. 13.
    Margolis RJ, Dover JS, Polla LL, et al. Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med. 1989;9:389-397.PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson RR, Margolis RJ, Watenabe S, et al. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol. 1989;93:28-32.PubMedCrossRefGoogle Scholar
  15. 15.
    Hruza GJ, Dover JS, Flotte TJ, et al. Q-switched ruby laser irradiation of normal human skin. Arch Dermatol. 1991;127:1799-1805.PubMedCrossRefGoogle Scholar
  16. 16.
    Murphy GF, Shepard RS, Paul BS, et al. Organelle-specific injury to melanin-containing cells in human skin by pulsed laser irradiation. Lab Invest. 1983;49:680-685.PubMedGoogle Scholar
  17. 17.
    Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77:13-19.PubMedCrossRefGoogle Scholar
  18. 18.
    Sherwood KA, Murray S, Kurban AK, Tan OT. Effect of wavelength on cutaneous pigment using pulsed irradiation. J Invest Dermatol. 1989;92:717-720.PubMedCrossRefGoogle Scholar
  19. 19.
    Nakamura Y, Hossain M, Hirayama K, Matsumoto K. A clinical study on the removal of gingival melanin pigmentation with the CO2 laser. Lasers Surg Med. 1999;25:140-147.PubMedCrossRefGoogle Scholar
  20. 20.
    Vikramaditya P, Bedi MS, et al. The effects of pulse energy variations on the dimensions of microscopic thermal treatment zones in nonablative fractional resurfacing. Lasers Surg Med. 2007;39:145-155.CrossRefGoogle Scholar
  21. 21.
    Ross EV, Ladin Z, Kreindel M, Dierickx C. Theoretical considerations in laser hair removal. Dermatol Clin. 1999;17:333-355.PubMedGoogle Scholar
  22. 22.
    Kono T, Manstein D, Chan HH. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med. 2006;38(2):94-97.PubMedCrossRefGoogle Scholar
  23. 23.
    Ueda S, Imayama S. Normal-mode ruby laser for treating congenital nevi. Arch Dermatol. 1997;133:355-359.PubMedCrossRefGoogle Scholar
  24. 24.
    Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol. 1993;32:908-912.PubMedCrossRefGoogle Scholar
  25. 25.
    Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium:yttrium-aluminum-garnet laser. J Dermatol Surg Oncol. 1994;20:795-800.PubMedGoogle Scholar
  26. 26.
    Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. Arch Dermatol. 1994;130:1515-1519.PubMedCrossRefGoogle Scholar
  27. 27.
    Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300 nsecond pulse and 510 nm wavelength. J Dermatol Surg Oncol. 1993;18:341-347.Google Scholar
  28. 28.
    Ashinoff R, Geronemus RG. Q-switched ruby laser treatment of labial lentigos. J Am Acad Dermatol. 1992;27:809-811.PubMedCrossRefGoogle Scholar
  29. 29.
    Gupta G, MacKay IR, MacKie RM. Q-switched ruby laser in the treatment of labial melanotic macules. Lasers Surg Med. 1999;25:219-222.PubMedCrossRefGoogle Scholar
  30. 30.
    Yung-Tsai L, Kao-Chia Y. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999;25:202-204.CrossRefGoogle Scholar
  31. 31.
    Todd M, Rallis T, Hata T. A comparison of three lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch Dermatol. 2000;50:536-540.Google Scholar
  32. 32.
    Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4:35-38.PubMedGoogle Scholar
  33. 33.
    Dover J et al. Adjunctive use of topical aminolevulinic acid with intense pulsed light in the treatment of photoaging. J Am Acad Dermatol. 2005;52:795-803.Google Scholar
  34. 34.
    Gold MH et al. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg. 2006;32(6):795-801.PubMedCrossRefGoogle Scholar
  35. 35.
    Tekin M, Bodurtha JN, Riccardi VM. Café au lait spots: the pediatrician’s perspective. Pediatr Rev. 2001;22:82-90.PubMedCrossRefGoogle Scholar
  36. 36.
    Grossman MC, Anderson RR, Farinelli W, et al. Treatment of cafe au lait macules with lasers: a clinicopathologic correlation. Arch Dermatol. 1995;131:1416-1420.PubMedCrossRefGoogle Scholar
  37. 37.
    Alster TS. Complete elimination of large cafe-au-lait birthmarks by the 510-nm pulsed dye laser. Plast Reconstr Surg. 1995;96:1660.PubMedCrossRefGoogle Scholar
  38. 38.
    Alora MB, Arndt KA. Successful treatment of a cafe-au-lait macule with the erbium:YAG laser. J Am Acad Dermatol. 2001;45(4):566-568.Google Scholar
  39. 39.
    Goldberg DJ. Benign pigmented lesions of the skin. J Dermatol Surg Oncol. 1993;19:376-379.PubMedGoogle Scholar
  40. 40.
    Rosio TJ. Techniques for tattoo removal. In: Wheeland RG, ed. Cutaneous Surgery. Philadelphia: WB Saunders; 1994:982-997.Google Scholar
  41. 41.
    Kobayashi T. Microsurgical treatment of nevus of Ota. J Dermatol Surg Oncol. 1991;17:936-941.PubMedGoogle Scholar
  42. 42.
    Clabaugh WA. Tattoo removal by superficial dermabrasion: five year experience. Plast Reconstr Surg. 1975;55:401-405.PubMedCrossRefGoogle Scholar
  43. 43.
    Koerber WA, Price NM. Salabrasion of tattoos: a correlation of the clinical and histological results. Arch Dermatol. 1978;114:884-888.PubMedCrossRefGoogle Scholar
  44. 44.
    Dvir E, Hirshowitz B. Tattoo removal by cryosurgery. Plast Reconstr Surg. 1980;66:373-378.PubMedCrossRefGoogle Scholar
  45. 45.
    Cosman B, Apfelberg DB, Drucker D. An effective cosmetic treatment for Ota’s nevus. Ann Plast Surg. 1989;22:36-42.PubMedCrossRefGoogle Scholar
  46. 46.
    Reid R, Muller S. Tattoo removal by CO2 laser dermabrasion. Plast Reconstr Surg. 1980;65:717-728.PubMedCrossRefGoogle Scholar
  47. 47.
    van Leeuwen RL, Dekker SW, Byers HR, et al. Modulation of α4β1 and α5β1 integrin expression: heterogenous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melanoma cells in vitro. Lasers Surg Med. 1996;18:63-71.PubMedCrossRefGoogle Scholar
  48. 48.
    Chan HH, Xiang K, Leung L, et al. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p161nk4a on melanoma cell lines. Lasers Surg Med. 2003;32(2):88-93.PubMedCrossRefGoogle Scholar
  49. 49.
    Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197:71-73.PubMedCrossRefGoogle Scholar
  50. 50.
    Grevelink JM, van Leeuwen RL, Anderson RR, Byers R. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol. 1997;133:349-353.PubMedCrossRefGoogle Scholar
  51. 51.
    Goldberg DJ, Zeichner JA, Hodulik SG, et al. Q-switched laser irradiation of pigmented nevi: analysis of markers for malignant transformation. Lasers Surg Med. 2006;18:18.Google Scholar
  52. 52.
    Vibhagool C, Byers R, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol. 1997;36:738-741.PubMedCrossRefGoogle Scholar
  53. 53.
    Rosenbach A, Williams CM, Alster TS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol Surg. 1997;23:239-245.PubMedCrossRefGoogle Scholar
  54. 54.
    Duke D, Byers R, Sober AJ, et al. Treatment of benign and atypical nevi with the normal-mode ruby laser and the Q-switched ruby laser: clinical improvement but failure to completely eliminate nevomelanocytes. Arch Dermatol. 1999;135:290-296.PubMedCrossRefGoogle Scholar
  55. 55.
    Baba M, Bal N. Efficacy and safety of the short-pulse erbium:YAG laser in the treatment of acquired melanocytic nevi. Dermatol Surg. 2006;32:256-260.PubMedCrossRefGoogle Scholar
  56. 56.
    Milgraum SS, Cohen ME, Auletta MJ. Treatment of blue nevi with the Q-switched ruby laser. J Am Acad Dermatol. 1995;32:307-310.PubMedCrossRefGoogle Scholar
  57. 57.
    Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med. 1994;331:1745-1750.PubMedCrossRefGoogle Scholar
  58. 58.
    Imayama S, Ueda S. Long- and short-term histological observations of congenital nevi treated with the normal-mode ruby laser. Arch Dermatol. 1999;135:1211-1218.PubMedCrossRefGoogle Scholar
  59. 59.
    Helsing P, Mork G, Sveen B. Ruby laser treatment of congenital melanocytic nevi – a pessimistic view. Acta Derm Venereol. 2006;86(3):235-237.PubMedCrossRefGoogle Scholar
  60. 60.
    Arndt KA. Argon laser treatment of lentigo maligna. J Am Acad Dermatol. 1984;10:953-957.PubMedCrossRefGoogle Scholar
  61. 61.
    Kopera D. Treatment of lentigo maligna with the carbon dioxide laser. Arch Dermatol. 1995;131:735-736.PubMedCrossRefGoogle Scholar
  62. 62.
    Thissen M, Westerhof W. Lentigo maligna treated with ruby laser. Acta Derm Venereol. 1997;77:163.PubMedGoogle Scholar
  63. 63.
    Arndt KA. New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. J Am Acad Dermatol. 1986;14:1092.PubMedCrossRefGoogle Scholar
  64. 64.
    Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.PubMedCrossRefGoogle Scholar
  65. 65.
    Hidano A, Kajama H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol. 1967;95:187-195.PubMedCrossRefGoogle Scholar
  66. 66.
    Jay B. Malignant melanoma of the orbit in a case of oculodermal melanocytosis (nevus of Ota). Br J Ophthalmol. 1965;49:359.PubMedCrossRefGoogle Scholar
  67. 67.
    Geronemus RG. Q-switched ruby laser therapy of nevus of Ota. Arch Dermatol. 1992;128:1618-1622.PubMedCrossRefGoogle Scholar
  68. 68.
    Lowe NJ, Wieder JM, Sawcer D, et al. Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser. J Am Acad Dermatol. 1993;29:997-1001.PubMedCrossRefGoogle Scholar
  69. 69.
    Taylor CR, Flotte TJ, Gange W, Anderson RR. Treatment of nevus of Ota by Q-switched ruby laser. J Am Acad Dermatol. 1994;30:743-751.PubMedCrossRefGoogle Scholar
  70. 70.
    Chang CJ, Nelson JS, Achauer BM. Q-switched ruby laser treatment of oculodermal melanosis (nevus of Ota). Plast Reconstr Surg. 1996;98:784-790.PubMedCrossRefGoogle Scholar
  71. 71.
    Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg. 1995;21:592-596.PubMedCrossRefGoogle Scholar
  72. 72.
    Lam AY et al. A retrospective study on the efficacy and complications of Q-switched alexandretie laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg. 2001;27(11):937-942.PubMedCrossRefGoogle Scholar
  73. 73.
    Manuskiatti W et al. Treatment of acquired bilateral nevus of Ota-like macules (Hori’s nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol. 2003;48(4):584-591.PubMedCrossRefGoogle Scholar
  74. 74.
    Polnikorn N et al. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg. 2000;26(5):477-480.PubMedCrossRefGoogle Scholar
  75. 75.
    Manuskiatte W, Sivayathorn A, Leelaudomlipi P, Fitzpatrick RE. Treatment of acquired bilateral nevua of Ota-like maculess (Hori’s nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol. 2003;48(4):584-591.CrossRefGoogle Scholar
  76. 76.
    Manuskiatti W et al. Effect of cold air cooling on the incidence of postinflammatory hyperpigmentation after Q-switched Nd:YAG laser treatment of acquired bilateral nevus of Ota-like macules. Arch Dermatol. 2007;143(9):1139-1143.PubMedCrossRefGoogle Scholar
  77. 77.
    Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20:592-597.PubMedGoogle Scholar
  78. 78.
    Nouri K, Bowes L, Chartier T, et al. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg. 1999;25:494-497.PubMedCrossRefGoogle Scholar
  79. 79.
    Manaloto RMP, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121-123.PubMedCrossRefGoogle Scholar
  80. 80.
    Narurkar VA. Skin rejuvenation with microthermal fractional photothermolysis. Dermatol Ther. 2007;20:S10-S13.PubMedCrossRefGoogle Scholar
  81. 81.
    Tannous Z, Astner S. Utilizing fractional resurfacing in the treatment of therapy resistant melasma. J Cosmet Laser Ther. 2005;7:39-43.PubMedCrossRefGoogle Scholar
  82. 82.
    Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;32:1645-1650.CrossRefGoogle Scholar
  83. 83.
    Lowe NJ, Wieder JM, Shorr N, et al. Infraorbital pigmented skin: preliminary observations of laser therapy. Dermatol Surg. 1995;21:767-770.PubMedCrossRefGoogle Scholar
  84. 84.
    West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surg. 1998;24:615-616.PubMedCrossRefGoogle Scholar
  85. 85.
    Manuskiatti W, Fitzpatrick RE, Goldman MP. Red ink tattoo reactions: successful treatment with the Q-switched 532 nm Nd:YAG laser. Dermatol Surg. 2000;26(2):113-120.CrossRefGoogle Scholar
  86. 86.
    Dwyer CM, Cuddihy AM, Kerr REI, et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol. 1993;129:158-162.PubMedCrossRefGoogle Scholar
  87.  87.
    Argenyi ZB, Finelli L, Bergfeld WF, et al. Minocycline-related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and X-ray energy spectroscopy. J Cutan Pathol. 1987;14:176-180.PubMedCrossRefGoogle Scholar
  88.  88.
    Collins P, Cotterill JA. Minocycline-induced pigmentation resolves after treatment with the Q-switched ruby laser. Br J Dermatol. 1996;135:317-319.PubMedCrossRefGoogle Scholar
  89.  89.
    Knoell KA, Milgraum SS, Kutenplon M. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation. Arch Dermatol. 1996;132:1251-1253.PubMedCrossRefGoogle Scholar
  90.  90.
    Tsao H, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol. 1996;132:1250-1251.PubMedCrossRefGoogle Scholar
  91.  91.
    Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201-1204.PubMedCrossRefGoogle Scholar
  92.  92.
    Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201-4.PubMedCrossRefGoogle Scholar
  93.  93.
    Wilde JL, English JC, Finley EM. Minocycline-induced hyperpigmentation: treatment with the neodymium:YAG laser. Arch Dermatol. 1997;133:1344-1346.PubMedCrossRefGoogle Scholar
  94.  94.
    Greve B, Schonermark MP, Raulin C. Minocycline-induced hyperpigmentation: treatment with the Q-switched Nd:YAG laser. Lasers Surg Med. 1998;22:223-227.PubMedCrossRefGoogle Scholar
  95.  95.
    Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol. 1999;135:251-253.PubMedCrossRefGoogle Scholar
  96.  96.
    Atkins DH, Fitzpatrick RE. Laser treatment of imipramine-induced hyperpigmentation. J Am Acad Dermatol. 2000;43(1):77-80.CrossRefGoogle Scholar
  97.  97.
    Trotter MJ, Tron VA, Hollingdale J, Rivers JK. Localized chrysiasis induced by laser therapy. Arch Dermatol. 1995;131:1411-1414.PubMedCrossRefGoogle Scholar
  98.  98.
    Yun PK, Arndt KA, Anderson RR. Q-switched laser-induced chrysiasis treated with long-pulsed laser. Arch Dermatol. 2002;138:1012-1014.PubMedCrossRefGoogle Scholar
  99.  99.
    Baggish MS, Poiesz BJ, Joret D, et al. Presence of human immunodeficiency virus DNA in laser smoke. Lasers Surg Med. 1991;11:197-203.PubMedCrossRefGoogle Scholar
  100. 100.
    Hirsch RJ, Anderson RR. Principles of Laser-Skin Interactions. In chapter 136, page 2148 in: Dermatology (ed.) Bolognia JL, Jorizzo JL, and Rapini RP. 1st edition, 2003.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  1. 1.Department of DermatologySkinCare PhysiciansChestnut HillUSA
  2. 2.Department of DermatologyBoston UniversityBostonUSA
  3. 3.Boston UniversityBostonUSA
  4. 4.Residency Training ProgramBostonUSA

Personalised recommendations